Taro Pharmaceutical Industries Investor Relations Material
Latest events
Q4 2024
20 May, 2024
Q3 2024
25 Jan, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Taro Pharmaceutical Industries Ltd
Access all reports
Taro Pharmaceutical Industries Ltd is a pharmaceutical company that develops, manufactures, and markets a range of prescription and over-the-counter medications. The company specializes in dermatological products, while also offering treatments in areas such as cardiology, neurology, and anti-inflammatory therapies. Taro focuses on producing generic pharmaceuticals, with a portfolio that includes creams, ointments, tablets, and liquids. Its products are distributed to markets globally, primarily in North America. The company is headquartered in Haifa Bay, Israel, and its shares are listed on the NYSE.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
TARO
Country
🇺🇸 United States